Same causes, same cures

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Alzheimer's disease (AD) and prion diseases (PDs) share common pathogenic mechanisms.
• These include oxidative stress, dysregulation of transition metal ions, and aberrant protein aggregation.
• Understanding these overlaps suggests potential for shared therapeutic strategies.

Purpose of the Study:

• To review existing therapeutic strategies for AD and PDs.
• To identify compounds effective against both diseases.
• To explore structural features of effective therapeutic agents.

Main Methods:

• Literature review of studies on AD and PD pathogenesis.
• Analysis of therapeutic agents targeting shared pathways.
• Identification of dual-acting compounds (dual fighters) and multi-targeting agents (super-dual-fighters).

Main Results:

• Identified antioxidants, metal chelators, and protein aggregation inhibitors as common therapeutic approaches.
• Highlighted specific compounds with dual efficacy against AD and PDs.
• Emphasized the structural importance of aromatic moieties and phenolic groups in these compounds.

Conclusions:

• Therapeutic strategies and potentially specific drugs can be shared between AD and PD treatments.
• Compounds with aromatic and phenolic structures show promise as 'super-dual-fighters'.
• Findings facilitate drug screening for both neurodegenerative diseases and deepen etiological understanding.